Cargando…

Berberine attenuates atherosclerotic lesions and hepatic steatosis in ApoE(-/-) mice by down-regulating PCSK9 via ERK1/2 pathway

BACKGROUND: It has been demonstrated that berberine (BBR), a kind of alkaloid derived from Chinese herbal medicine, has multiple pharmacological effects on human’s diseases including anti-atherosclerosis action. However, although the previous studies showed that the beneficial impact of BBR on ather...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Chun-Yan, Shi, Xiao-Yun, Wu, Ya-Ru, Zhang, Yue, Yao, Yu-Hong, Qu, Hui-Lin, Zhang, Wei, Guo, Yuan-Lin, Xu, Rui-Xia, Li, Jian-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576642/ https://www.ncbi.nlm.nih.gov/pubmed/34790723 http://dx.doi.org/10.21037/atm-20-8106

Ejemplares similares

Berberine derivatives reduce atherosclerotic plaque size and vulnerability in apoE(−/−) mice
por: Chen, Junwen, et al.
Publicado: (2014)

Berberine: Ins and outs of a nature-made PCSK9 inhibitor
por: Ataei, Sarina, et al.
Publicado: (2022)

Notoginsenoside R1 Attenuates Atherosclerotic Lesions in ApoE Deficient Mouse Model
por: Jia, Chenglin, et al.
Publicado: (2014)

Adoption of PCSK9 Inhibitors Among Patients With Atherosclerotic Disease
por: Dayoub, Elias J., et al.
Publicado: (2021)

Role of PCSK9 in Homocysteine-Accelerated Lipid Accumulation in Macrophages and Atherosclerosis in ApoE(−/−) Mice
por: Jin, Ping, et al.
Publicado: (2021)

Diminazene Aceturate Stabilizes Atherosclerotic Plaque and Attenuates Hepatic Steatosis in apoE-Knockout Mice by Influencing Macrophages Polarization and Taurine Biosynthesis
por: Stachowicz, Aneta, et al.
Publicado: (2021)

SUN-580 PCSK9 and Lp(a): Association Between PCSK9 Level and Larger Apo(a) Isoform Size in African-Americans and Caucasians
por: Byambaa, Enkhmaa, et al.
Publicado: (2020)

Berberine Attenuates Arterial Plaque Formation in Atherosclerotic Rats with Damp-Heat Syndrome via Regulating Autophagy
por: Ke, Xiao, et al.
Publicado: (2020)

Berberine activates peroxisome proliferator‐activated receptor gamma to increase atherosclerotic plaque stability in Apoe (−/−) mice with hyperhomocysteinemia
por: Li, Hongjun, et al.
Publicado: (2016)

Effect of PCSK9 inhibition in combination with statin therapy on intracranial atherosclerotic stenosis: A high-resolution MRI study
por: Wu, Lingshan, et al.
Publicado: (2023)

Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine
por: De Castro-Orós, Isabel, et al.
Publicado: (2016)

Fisetin ameliorates atherosclerosis by regulating PCSK9 and LOX-1 in apoE(-/-) mice
por: Yan, Li, et al.
Publicado: (2021)

Effect of PCSK9 on atherosclerotic cardiovascular diseases and its mechanisms: Focus on immune regulation
por: Ma, Minglu, et al.
Publicado: (2023)

PCSK9 in African Americans and Caucasians in Relation to Lp(a) Level, Apo(a) Size and Heritability
por: Enkhmaa, Byambaa, et al.
Publicado: (2020)

PCSK9 attenuates efferocytosis in endothelial cells and promotes vascular aging
por: Liu, Shijie, et al.
Publicado: (2023)

The Effect of PCSK9 Inhibition on the Stabilization of Atherosclerotic Plaque Determined by Biochemical and Diagnostic Imaging Methods
por: Basiak, Marcin, et al.
Publicado: (2023)

Metformin Ameliorates Hepatic Steatosis induced by olanzapine through inhibiting LXRα/PCSK9 pathway
por: Zhu, Wenqiang, et al.
Publicado: (2022)

Ossabaw Pigs With a PCSK9 Gain‐of‐Function Mutation Develop Accelerated Coronary Atherosclerotic Lesions: A Novel Model for Preclinical Studies
por: Yuan, Fang, et al.
Publicado: (2018)

Canagliflozin Attenuates Hepatic Steatosis and Atherosclerosis Progression in Western Diet-Fed ApoE-Knockout Mice
por: Zuo, Qingjuan, et al.
Publicado: (2022)

Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice
por: Lu, Yonggang, et al.
Publicado: (2017)

Variations in TM6SF2, PCSK9 and PCSK7 genes and risk of hepatic steatosis after liver transplantation: a cross-sectional study
por: Eshraghian, Ahad, et al.
Publicado: (2021)

Enhanced circulating PCSK9 concentration by berberine through SREBP-2 pathway in high fat diet-fed rats
por: Jia, Yan-Jun, et al.
Publicado: (2014)

Di’ao Xinxuekang Capsule Improves the Anti-Atherosclerotic Effect of Atorvastatin by Downregulating the SREBP2/PCSK9 Signalling Pathway
por: Liang, Jiyi, et al.
Publicado: (2022)

Intraperitoneal Injection of Human Ferritin Heavy Chain Attenuates the Atherosclerotic Process in APOE-Knockout Mice
por: Yuan, Wanzhong, et al.
Publicado: (2023)

Decreased APOE-containing HDL subfractions and cholesterol efflux capacity of serum in mice lacking Pcsk9
por: Choi, Seungbum, et al.
Publicado: (2013)

Anti-PCSK9 antibodies inhibit pro-atherogenic mechanisms in APOE*3Leiden.CETP mice
por: Schuster, Susanne, et al.
Publicado: (2019)

MiR-4291 stabilized the vulnerable atherosclerotic plaques by degrading the MAPK1/ERK2 in ApoE(-/-) mice
por: Jin, Yaqiong, et al.
Publicado: (2022)

Investigation of highly expressed PCSK9 in atherosclerotic plaques and ox-LDL-induced endothelial cell apoptosis
por: Li, Jiao, et al.
Publicado: (2017)

Trends in PCSK9 Inhibitor Prescriptions before and after the Price Reduction in Patients with Atherosclerotic Cardiovascular Disease
por: Smith, Alex, et al.
Publicado: (2021)

PCSK9 is minimally associated with HDL but impairs the anti-atherosclerotic HDL effects on endothelial cell activation
por: Dafnis, Ioannis, et al.
Publicado: (2022)

Functional nano-vector boost anti-atherosclerosis efficacy of berberine in Apoe((−/−)) mice
por: Ma, Xiaolei, et al.
Publicado: (2020)

Dennd5b-Deficient Mice are Resistant to PCSK9-Induced Hypercholesterolemia and Diet-Induced Hepatic Steatosis
por: Mobilia, Maura, et al.
Publicado: (2022)

Methyltransferase SETD2 mediates hepatoprotection of berberine against steatosis
por: Dai, Li, et al.
Publicado: (2022)

Hyperlipidemia-induced apoptosis of hippocampal neurons in apoE(−/−) mice may be associated with increased PCSK9 expression
por: Zhao, Xue-Shan, et al.
Publicado: (2017)

The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels
por: Drouin-Chartier, Jean-Philippe, et al.
Publicado: (2017)

Susceptibility of ApoB and PCSK9 Genetic Polymorphisms to Diabetic Kidney Disease Among Chinese Diabetic Patients
por: Ma, Liang, et al.
Publicado: (2021)

The combination of L-4F and simvastatin stimulate cholesterol efflux and related proteins expressions to reduce atherosclerotic lesions in apoE knockout mice
por: Ying, Ru, et al.
Publicado: (2013)

Pcsk9 is associated with severity of coronary artery lesions in male patients with premature myocardial infarction
por: Gao, Jing, et al.
Publicado: (2021)

Berberine ameliorates non-alcoholic steatohepatitis in ApoE(−/−) mice
por: Yang, Jin, et al.
Publicado: (2017)

Kefir peptides attenuate atherosclerotic vascular calcification and osteoporosis in atherogenic diet-fed ApoE (−/−) knockout mice
por: Chang, Gary Ro-Lin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lre1rkrv4vr1hfj8bk20hbbdv7